Zwj Investment Counsel Inc Agios Pharmaceuticals, Inc. Transaction History

Zwj Investment Counsel Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 26, 2021	SELL	$33.21 - $46.54 $5.71 Million - $8 Million	-171,982 Closed	0 $0
Q3 2020 Nov 03, 2020	SELL	$33.87 - $55.93 $122,948 - $203,025	-3,630 Reduced 2.07%	171,982 $6.02 Million
Q2 2020 Jul 28, 2020	BUY	$34.45 - $53.48 $550,166 - $854,075	15,970 Added 10.0%	175,612 $9.39 Million
Q1 2020 May 18, 2020	BUY	$31.52 - $53.81 $71,455 - $121,987	2,267 Added 1.44%	159,642 $5.66 Million
Q4 2019 Feb 13, 2020	BUY	$30.08 - $50.59 $1.23 Million - $2.07 Million	40,966 Added 35.19%	157,375 $7.52 Million
Q3 2019 Oct 22, 2019	BUY	$32.4 - $49.58 $1.01 Million - $1.55 Million	31,180 Added 36.58%	116,409 $3.77 Million
Q2 2019 Jul 24, 2019	BUY	$46.17 - $68.1 $3.94 Million - $5.8 Million	85,229 New	85,229 $4.25 Million

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.05B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Zwj Investment Counsel Inc, based on Form 13F filings with the SEC.

Stay updated on Zwj Investment Counsel Inc with notifications on news.